Novel Biomarker Discovery Using Metabolomics
Felice de Jong, Director, Metabolon Inc. speaking at the European Biomarkers Summit 2006.
LC/MS/MS Solutions for Targeted and Non-Targeted Small Molecule and Protein Biomarker Discovery, Verification and Validation
Henri Snijders, European Marketing Manager Small Molecules, Applied Biosystems speaking at the European Biomarkers Summit 2006.
Novel Approach to Active Metabolite Identification Allowing Early Access to Metabolic Profiling Studies to Improve Lead Candidate Selection
Dr. Danny van Elswijk, Screening Director, Kiadis BV, speaking at Advances in Metabolic Profiling 2005.
Identification of Major Metabolism Regulators from Metabolic Profiles
Dr. Anton Yuryev, Executive Director of Application Science, Ariadne Genomics Inc., speaking at Advances in Metabolic Profiling 2005.
Metabolomics in the Drug Discovery Process: Interactions With Other -omes
Dr Julian L. Griffin, University of Cambridge speaking at Advances in Metabolomic Profiling 2005.
Predicting Clinical Resistance to Gleevec Treatment by in vitro Applied Stable Isotope-based Dynamic Metabolic Profiling
Laszlo G. Boros, Los Angeles Biomedical Research Institute at UCLA and SIDMAP, LLC, speaking at Advances in Metabolic Profiling 2005
Metabolic Profiles and Biomarkers for Detection and Prediction of Drug Effects
Hans Senn of F. Hoffmann-La Roche AG speaking at Advances in Metabolic Profiling 2005.
Predicting the Safety of FDA Regulated Products with Metabolomics
Laura Schnackenberg, Center for Metabolomics Research, speaks at Advances in Metabolic Profiling 2005.
The Application of Metabolic Profiling Techniques in Biomarker Discovery in Drug R&D
Dr. Ina Schuppe Koistinen, AstraZeneca R&D speaking at Advances in Metabolic Profiling 2005
|<< || 1 2 3 4 5 6 7 ||>>|
|Showing Results 61 - 70 of 70|